A compassionate use program of SM-88

Trial Profile

A compassionate use program of SM-88

Recruiting
Phase of Trial: Clinical Phase Unknown

Latest Information Update: 22 Jan 2018

At a glance

  • Drugs SM 88 (Primary)
  • Indications Breast cancer; Colon cancer; Glioma; Lymphoma; Ovarian cancer; Pancreatic cancer; Prostate cancer; Sarcoma
  • Focus Expanded access; Therapeutic Use
  • Most Recent Events

    • 22 Jan 2018 New trial record
    • 19 Jan 2018 According to a Tyme Technologies media release, results from patients (n=10) with pancreatic cancer from this or compassionate use program were presented in a poster presentation at the 2018 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium.
    • 19 Jan 2018 Results from patients (n=10) with pancreatic cancer from this or compassionate use program presented in a Tyme Technologies media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top